Crinetics Pharma

$20.55 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Crinetics Pharma

Crinetics Pharmaceuticals, Inc. is a United States-based therapeutics company. The Company is focused on discovery, development, and commercialization of oral nonpeptide therapeutics for endocrine diseases and endocrine-related tumors. It uses a pipeline of oral nonpeptide (small molecule) new chemical entities that targets peptide G protein coupled receptors (GPCRs) to treat a variety of endocrine diseases. The Company's product range includes CRN00808, for the treatment of acromegaly; CRN02481, for the treatment of hyperinsulinemias; CRN01941, for the treatment of neuroendocrine tumors (NETs).

Stock Analysis

last close $20.55
1-mo return 1.1%
3-mo return 16%
avg daily vol. 271.03T
52-week high 28.95
52-week low 15.91
market cap. $1.2B
forward pe -
annual div. -
roe -52.8%
ltg forecast -
dividend yield -
annual rev. $4M
inst own. 89%
baraka

Subscribe now for daily local and international financial news

Subscribe